Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vitamin D and topical therapy.

Mark Lebwohl1

  • 1Department of Dermatology, The Mount Sinai School of Medicine, New York, New York, USA.

Cutis
|December 7, 2002
PubMed
Summary
This summary is machine-generated.

A sequential therapy using calcipotriene and halobetasol effectively manages chronic plaque psoriasis. This regimen achieved higher remission rates compared to monotherapy or placebo, offering a viable treatment option.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Remibrutinib impact on disease control, sleep, and quality of life: Analysis of phase 3 REMIX-1/2.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Guselkumab Safety in Patients With Latent Tuberculosis: Analysis of 11 Studies in Psoriatic Disease.

The Journal of dermatology·2026
Same author

Ixekizumab With or Without Tirzepatide in Adults With Psoriasis and Overweight or Obesity: A Phase 3b Randomized Clinical Trial.

JAMA dermatology·2026
Same author

Summary of Research: Apremilast Improves Skin Outcomes in Pediatric Plaque Psoriasis of Shorter Disease Duration: 52-Week Results from the SPROUT Phase 3 Trial.

Dermatology and therapy·2026
Same author

The Misdiagnosis of Pemphigus Foliaceus as Psoriasis.

International journal of dermatology·2026
Same author

Efficacy and Safety of Cosibelimab for Advanced Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel.

Journal of drugs in dermatology : JDD·2026
Same journal

A Solitary Axillary Subcutaneous Mass.

Cutis·2026
Same journal

Microcystic Adnexal Carcinoma-like Neoplasm in a Patient With POT1 Mutation.

Cutis·2026
Same journal

A Hybrid Suture Technique: Suture Modification With Dental Roll Insertion.

Cutis·2026
Same journal

Beyond Conventional Paradigms: Rethinking the Evaluation and Management of Melasma.

Cutis·2026
Same journal

Social Drivers of Health Curriculum for Dermatology Residents: the UCSF Experience.

Cutis·2026
Same journal

Hospital Dermatology: Review of Research in 2024-2025.

Cutis·2026
See all related articles

Area of Science:

  • Dermatology
  • Pharmacology

Background:

  • Chronic plaque psoriasis requires effective management strategies.
  • Topical therapies are a cornerstone of psoriasis treatment.

Purpose of the Study:

  • To evaluate a sequential therapy regimen for chronic plaque psoriasis.
  • To assess the efficacy of calcipotriene and halobetasol combination therapy.

Main Methods:

  • An initial 2-week clearing phase with daily calcipotriene and halobetasol ointments.
  • A sequential maintenance phase with calcipotriene on weekdays and halobetasol on weekends.
  • Comparison with monotherapy and placebo groups.

Main Results:

  • Combined calcipotriene and halobetasol were superior to monotherapy during the clearing phase.

Related Experiment Videos

  • The sequential regimen maintained remission in 76% of patients for up to 6 months.
  • Significantly higher remission rates were observed compared to halobetasol monotherapy on weekends (40%) and placebo.

    • Conclusions:

    • Sequential therapy with calcipotriene and halobetasol is an effective strategy for chronic plaque psoriasis management.
    • The compatibility of calcipotriene and halobetasol supports their combined use.
    • This regimen offers a promising approach for achieving and maintaining long-term remission.